Search

everythinglearnresearchcommunity

for

Search:↓

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Individualized assessment and meticulous planning are crucial for successful brow and upper eyelid surgery.

Blocking interferon-gamma might help treat various autoimmune diseases.

Common noncancerous skin diseases have various treatments, including topical applications, light therapy, surgery, and medications, with psychological support being important.

The document lists various dermatology topics, treatments, and diagnostic methods.

UVB is good for a skin condition in Asian kids, a lotion works for head lice, a drug helps with a skin blistering disorder, a foam reduces itchiness in skin inflammation, birthmarks can be more widespread, and criteria for a neurocutaneous disorder were agreed upon.

The new method combining dermoscopy and Reflectance Confocal Microscopy is more effective for evaluating vitiligo.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Dermoscopic features can help identify and differentiate types of pityriasis versicolor.

Yellow dots are common in severe alopecia areata.

Most vitiligo patients in Makkah are young women, often with family history and thyroid issues.

The document concludes that while white skin, nail, and mucosa diseases increase skin cancer risk, they are generally harmless, especially compared to darker pigmentation conditions.

Vitiligo and lupus can occur together, requiring careful treatment to manage both conditions.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Melanocyte stem cells are crucial for skin pigmentation and have potential in disease modeling and regenerative medicine.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

The document concludes that accurate diagnosis of alopecia in children relies on thorough examination and history, and while treatments exist, none can alter the course of alopecia areata, which can significantly affect a child's psychological well-being.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Autologous platelet concentrates show promise in esthetic treatments but need more standardized research.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

A new mouse model for vitiligo helps study immune responses and potential treatments.

Diphencyprone can cause unexpected and possibly permanent vitiligo.

Most injecting drug users in the study had hepatitis C and skin problems, which moderately affected their quality of life.

Topical immunotherapy is the best treatment for severe alopecia areata.

Common skin conditions can greatly affect a person's mental health and social life.

Stem-cell therapy shows promise for skin conditions but needs more research.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

Apremilast did not work for treating severe alopecia areata.

Human skin's melanocytes respond to light by changing shape, producing pigments and hormones, which may affect sleep patterns.

A new gene mutation may allow some piebaldism patients to regain skin color in white patches.